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Abstract 
Different cell types have different post-mitotic maintenance requirements. Nerve cells, however, are unique in 
this respect as they need to survive and preserve their functional complexity for the entire lifetime of the 
organism and failure at any level of their supporting mechanisms, leads to a wide range of neurodegenerative 
conditions. Whether these differences across tissues arise from the activation of distinct cell type-specific 
maintenance mechanisms or the differential activation of a common molecular repertoire is not known. 
In order to identify the transcriptional signature of post-mitotic cellular longevity (PMCL), we compared 
whole genome transcriptome data from human tissues ranging in longevity from 120 days to over 70 years and 
found a set of 81 genes whose expression levels are closely associated with increased cell longevity. Using 
expression data from ten independent sources, we found that these genes are more highly co-expressed in 
longer living tissues and are enriched in specific biological processes and transcription factors targets 
compared to randomly selected gene samples. Crucially, we found that PMCL-associated genes are down-
regulated in the cerebral cortex and substantia nigra of Alzheimer’s and Parkinson’s disease patients as well as 
Hutchinson-Gilford progeria-derived fibroblasts, and that this down regulation is specifically linked to their 
underlying association with cellular longevity.  Moreover, we found that sexually dimorphic brain expression 
of PMCL-associated genes reflects sexual differences in lifespan in humans and macaques.  Taken together 
our results suggest that PMCL-associated genes are part of a generalized machinery of post-mitotic 
maintenance and functional stability in both neural and non-neural cells and support the notion of a common 
molecular repertoire differentially engaged in different cell types with different survival requirements.  
 
Keywords:  
neuronal longevity; 
 tissue maintenance; 
 transcriptional signature;  
Neuronal ageing. 
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1.0  Introduction 
In multicellular organisms, most cells have a shorter lifespan than the organism and are continuously replaced. 
However not all cell types are replaced at similar rates. Differential demands in turnover across different cell 
types are necessarily matched by corresponding differences in post-mitotic maintenance. When measured in 
terms of post-mitotic rate of survival, these differences in requirements range in humans from a few days in 
skin cells and gut epithelium, to several months or years in the case of bones and muscles (Spalding et al., 
2005).  
Although the need for long term survival is common to many cell types, nowhere is post-mitotic cell 
maintenance more critical than in neurons as mature post-mitotic neurons need to survive and preserve their 
functional complexity during the entire lifetime of an individual (Magrassi et al., 2013).  More importantly, 
failure at any level in the underlying supporting mechanisms, leads to a wide range of neurodegenerative 
conditions (Drachman, 1997; Fishel et al., 2007; Mattson and Magnus, 2006).  
Cellular maintenance in neurons and other cell types is likely to be the result of a wide network of interacting 
molecular mechanisms that act at several levels of the cell’s physiology to ensure its structural and functional 
stability (Lanni et al., 2010; Mattson and Magnus, 2006). Identifying these molecular networks is critically 
important in order to understand both cell survival and its pathological counterpart, cell degeneration. 
Current research on neuronal long term survival and maintenance mainly focuses in the study of the signalling 
events that regulate programmed neuronal death during development or the abnormal reduction in cellular 
support leading to cell death in models of injury or neurotoxicity (Harrington and Ginty, 2013; Jaiswal et al., 
2012; Lanni et al., 2010). During development, neurons freely activate cell death pathways to fine-tune the 
number of neurons that are needed during the precise formation of neural networks. These cell death pathways 
are remarkably active during early development, and although they become highly restricted as neurons 
mature, negative regulation of cell death alone is unlikely to account the characteristic long-term survival 
potential of nerve cells (Kole et al., 2013).  
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Specific regulatory events directing post-mitotic survival are known to vary across cell types. Thus, for 
instance, in developing neurons post-mitotic survival is mostly regulated by neurotrophins and their associated 
receptors and signalling networks (Cole and Frautschy, 2007; Harrington and Ginty, 2013; Lanni et al., 2010; 
Mattson and Magnus, 2006). In other cell types, such as plasma B cell, post-mitotic survival is known to 
respond to the regulatory control of a different array of extrinsic signals including member of the TNF 
superfamily of ligands, interleukin 4,5 and 6, CXCL12 and others (Benson et al., 2008; Cassese et al., 2003; 
Mattison et al., 2012; O'Connor et al., 2004).   
Regardless of the specific regulatory mechanisms engaged by different terminally differentiated post-mitotic 
cell types, the basic molecular events ensuring appropriate levels of DNA repair, protein stability, protein 
turnover capacity and organelle integrity could conceivably recruit a common repertoire of molecular 
mechanisms with the only difference being their level of activation of these mechanisms in response to the 
survival requirements of different cell types and tissues.  
Because little is known of the molecular determinants specifically accounting for differences in post-mitotic 
maintenance across cell types, whether these differences result from the activation of distinct cell type-specific 
maintenance mechanisms or the variable activation of an otherwise common molecular repertoire is not 
known. 
In human tissues, our knowledge regarding post-mitotic cell longevity and turnover has been scarce in the past 
due to the lack of means to accurately measure cell turnover in human subjects. In recent years, however, 14C-
based retrospective birth dating has been successfully used to estimate the rate of cell turnover in several 
human tissues (Bhardwaj et al., 2006; Spalding et al., 2005).  Taking advantage of the availability of these 
estimates for seven human tissues ranging in longevity from 120 day to over 70 years, here we set out to 
identify the molecular signature of long term post-mitotic maintenance. To this end, we conducted genome-
wide comparisons of human transcriptome data derived from these tissues and screened for genes whose 
expression patterns are closely associated with changes in post-mitotic cell longevity. 
We identified a set of PMCL associated genes whose expression levels are robustly and consistently 
associated with increased cell longevity.  Using expression data from ten independent sources (Table 1),  we 
further found that: 1) these genes display a high level of co-expression in nerve cells and other long living 
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tissues compared to random expectations suggesting a functional association between these genes; 2) they are 
also significantly enriched in specific biological processes and transcription factors targets further supporting 
the notion that these genes share related biological functions in addition to common regulatory pathways; 3) 
PMCL-associated genes are down-regulated in the cerebral cortex and substantia nigra of Alzheimer’s and 
Parkinson’s disease patients respectively, as well as Hutchinson-Gilford progeria-derived fibroblasts; 4) 
sexually dimorphic brain expression of PMCL-associated genes reflects sexual differences in lifespan in 
humans and macaques. Our results support the notion of generalised cell longevity pathways in human tissues 
differentially engaged in different cell types with different survival requirements. 
2.0.  Materials and Methods 
2.1.  Cellular longevity estimates 
 Cellular longevity estimates based on quantification of 14C in genomic DNA from 7 somatic tissues 
(adipocyte, cardiac myocytes, cerebellum, pancreatic islet, skeletal muscle, leukocytes and small intestine) 
were obtained from Spalding et al (2005), and associated literature sources (Supplementary table 1). 
2.2.  Sources and selection of gene expression data 
 GCRMA-normalized cell type specific patterns of mRNA expression for seven tissues for which cell 
longevity data is available, were extracted from the Affymetric GeneChip HG-133U part of the Human 
U133A/GNF1H Gene Atlas dataset, which comprises transcriptome data for 79 human tissue samples and cell 
lines (Dataset 1). While occipital cortex expression data was also available, only data from cerebellum was 
initially included in order to avoid unnecessary overrepresentation of nervous tissue in our initial tissue 
samples. Probe sets were mapped to Ensembl gene IDs via probe set annotations downloaded from the 
Ensembl’s biomart database (v.71). Where more than one probe mapped to a single gene ID, expression 
measurements were averaged. Any probe matching more than one gene ID was eliminated from the analysis. 
Probes with zero variance in expression levels across tissues were excluded together with non-protein coding 
genes. This reduced our background population of genes to a total of 11 449 genes. In order to correct for 
variations in total signal across tissues, individual expression values were renormalized against the total 
expression signal per tissue. All the expression data obtained from the sources listed in Table 1 was processed 
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in a similar way. Briefly, expression data from brain, muscle and skin from Gene Expression Omnibus (GEO) 
(GSE13162, GSE11681 and GSE42114 respectively, Dataset 2, Table 1) were selected due to the similarity of 
the microarray platforms and the availability of several normal replicas allowing a reliable assessment of co-
expression. As before, we summarized to Ensembl gene ID all RMA-normalized expression values which 
were then normalized by the total intensity per sample. RNA-seq expression data (RPKM-normalized and 
summarized to Ensembl gene ID as described above) was downloaded from Brainspan database 
(http://www.brainspan.org/, Dataset 3, Table 1). Data for all 12 cortical areas present in this database across 20 
different ages were extracted from this source for subsequent analyses. We further normalized individual 
expression values within samples against the total level of gene expression in each sample. Where more than 
one sample was available for the same age, expression values from equivalent samples were averaged. The 
same procedure was followed for the transcriptome data of the 15 cortical areas present for both 40 year old 
male and female samples used in Figure 5. RPKM normalized RNA-seq expression levels for human and 
macaque orthologous genes from both male and female individuals were obtained from Brawand et al. dataset 
(Brawand et al., 2011). Individual expression values were again normalized against total signal per sample 
(Dataset 5, Table 1). Microarray derived, RMA normalized values of gene expression values derived from 
sutstantia nigra of Parkinson’s disease patients or Hutchinson Gilford Progeria Syndrome-derived fibroblasts 
and their corresponding controls were obtained from NCBI’s GEO (Dataset 4, Table 1). Raw CEL files for 
arrays with gene expression levels in tissues with Alzheimer’s disease were also downloaded from GEO. The 
later were RMA-normalized for consistency. We summarized per probe expression levels to ensemble gene 
IDs in the same manner as with the Human Gene Atlas data set and renormalized against the total expression 
signal in each array/sample. Finally, RMA-normalized microarray data from neocortex mice under CR and Z-
normalized microarray data for skeletal muscle of individuals subject to CR were downloaded from GEO 
(Dataset 6, Table 1and processed as previously described. 
2.3.  Co-expression analyses 
 Co-expression analyses were carried out by obtaining the correlation coefficient across all possible pairs of 
PMCL-associated genes in the brain cortex. To evaluate whether PMCL-associated genes were highly co-
expressed, relative to background gene population, using any given dataset, the corresponding p-value was 
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numerically determined by comparing the mean co-expression of PMCL-associated genes with the expected 
distribution of mean co-expression values computed from 100 000 random gene samples of the same size. 
Comparisons of mean co-expression of PMCL-associated genes across tissues and/or samples were carried out 
by paired t-tests.  
2.4.  Enrichment of disease down-regulated genes 
 Differential expression analysis was carried out using the disease expression datasets to compare disease 
against control conditions for each case of study using the LIMMA package in R (Smyth, 2005). Significant 
biases in the proportion of disease-related down-regulated genes among our set of PMCL-associated genes 
was assessed by contrasting the observed proportion of these genes with the ones observed in at least 1 000 
000 equally sized random sampled obtained from the background gene population. The test involving 
differentially down-regulated genes in 40 years old human males when compared to females was done in the 
same following the same approach.  
2.5.  Functional enrichment analysis 
 Biological Process GO Slim annotations where obtained from Ensembl’s (release 71) Biomart.  Entrez IDs 
and Gene symbols annotations for Transcription factor target sites where obtained from the Molecular 
Signatures Database v4.0 (MSigDB) (http://www.broadinstitute.org/gsea/msigdb/index.jsp). These annotations 
are based on transcription factor binding sites defined in the TRANSFAC (version 7.4, http://www.gene-
regulation.com/) database. Entrez IDs and Gene symbols where mapped to Ensembl IDs with a 
correspondence table downloaded from Ensembl’s Biomart. Gene sets sharing a binding site labelled as 
UNKNOWN where excluded from this analysis. To measure the enrichment in genes with any target binding 
site for a given transcriptional factor, we summarized TRANSFAC annotations by assigning a gene to a 
transcription factor if it contains any target for that TF in TRANSFAC annotations. 
For consistency across all different enrichment analyses carried out, and in order to facilitate the use of the 
same Ensembl version throughout the study, we employed our own numerical methods to assess significant 
over-representation. Briefly, statistical enrichment of each analysed category (i.e., gene ontology, disease-
down-regulated genes, transcription factor targets, sex-specific differentially expressed genes, caloric 
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restriction-associated genes etc.) among our set of PMCL-associated genes was assessed by performing a Z–
test, where the expected representations and their standard deviations were obtained from 1 000 000 Monte 
Carlo simulations using random samples of 81 genes drawn from our curated set of 11 449 genes. Benjamini-
Hochberg multiple testing corrections against the number of categories tested in each analysis was done (GO 
slim functional categories, n = 69, TRANSFAC specific factor target binding site, n = 501, TRASFAC 
summarized to transcription factors, n = 283). Categories with a resulting adj. p < 0.05 and with an excess of 
more than 1 PMCL-associated gene than expected, were deemed significantly enriched.  
Statistical analysis. All statistical analyses were carried out using the R statistical software package. 
 
3. Results  
3.1.  
We started by reasoning that if there is a general cell maintenance machinery in human tissues differentially 
engaged in different cell types with different survival requirements, we would expect this hypothetic pathway 
to involve a relatively large number of genes whose levels of expression are also expected to display a strong 
association with increased post-mitotic cellular longevity (PMCL).  We tested this hypothesis by looking at 
transcriptional profiles across a number of tissues for which accurate estimates of post-mitotic survival or 
cellular longevity are available and compared the overall correlation between gene expression values and 
PMCL with the mean correlation expected by chance. 
 To this end we used cell longevity estimates obtained from 14C-based retrospective birth dating for 
cerebellum, cardiac myocytes, pancreatic islet, small intestine (parenchyma), skeletal muscle, adipocytes and 
leukocytes, ranging in longevity from 120 days to over 70 years (Supplemetary table 1) (Bergmann et al., 
2009; Perl et al., 2010; Spalding et al., 2005; Whitehouse et al., 1982). Expression data was extracted from the 
Affymetrix GeneChip HG-133U part of the Human U133A/GNF1H Gene Atlas data set, which compiles 
microarray gene expression data for 79 human tissue samples and cell lines (Dataset 1, Table 1; see methods).  
To obtain an unbiased estimator of the degree of association between the expression level across the above 
seven tissues and the cellular longevity estimates for the same tissues, we computed a jackknife correlation for 
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each gene. That is, a sequence of seven pseudovalues is calculated by obtaining the Pearson correlation 
coefficient while dropping in turn each of the tissues from the analysis. The jackknife correlation is then 
defined as the mean of these pseudo-values. This process was repeated for each of the 11 449 genes for which 
expression data were available in all seven tissues and the overall mean Jackknife correlation was computed.  
To estimate the degree of statistical bias in this value compared to chance expectations, we repeated the exact 
same analysis using 1000 random permutations of cellular longevity estimates. As shown in figure 1A, global 
expression patterns showed an overall and highly significant bias towards a positive association between 
expression levels across the whole gene population and PMCL. This result indicates a robust signature of 
PMCL at the level of gene expression across different tissues and reveals the existence of a substantial 
proportion of PMCL-associated genes relative to chance expectations. 
In order to indentify a defined set of strong transcriptional correlates of enhanced cellular maintenance in 
nervous tissue as well as other cell types, we screened for genes whose expression patterns met two 
independent criteria: First we looked for genes whose pattern of expression were strongly and consistently 
associated with changes in cell longevity across different tissues. Second, because a complex phenotype is 
usually the result of an assembly of molecular and genetic components acting in concert (Hartwell et al., 1999)  
and genes involved in related biological pathways display correlated expression patterns reflecting their 
functional association (Eisen et al., 1998; Homouz and Kudlicki, 2013), we selected, among those genes 
meeting the first criterion, those that also displayed a consistent association with each other across a wider 
range of tissues not included in the selection based on the first criterion.  
 
To screen for genes meeting the first criterion, we used the Jackknife correlations obtained for all 11 449 
genes in our previous analysis and selected those genes with an absolute Jackknife correlation coefficient 
value greater than 0.8. The way in which this estimator is computed, in combination a high cut-off value, 
ensures that we eliminate the spurious contribution of potentially strong outliers in the reference tissues (such 
as nervous tissue).  This approach identified a set of 98 genes with Jackknife values ranging from 0.801 to 
0.972.  Interestingly, no genes were identified in the negative tail of the resulting distribution.  
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In order to select, among those genes meeting the first criterion, those that also displayed a consistent 
association with each other across a wider range of tissues (criterion 2); from our original set of 98 candidate 
genes we identified those genes that also display a strong correlation with at least two other genes within this 
set when examining their collective pattern of co-expression across an independent set of tissues. Taking 
advantage of the fact that Dataset 1 also compiles expression data for over 28 separate tissues, we extracted 
the Pearson correlation values of all possible pairs of these genes across 21 tissues not included in the first 
analysis and looked for a single connected component or network linked by strong correlations (R > 0.8). This 
screening revealed a single cluster of 81 genes, all of which linked with at least two other genes in these set by 
a strong R > 0.8 correlation, leaving only 17 isolated genes.  Figure 1B shows the average expression of our 
selected set of 81 PMCL-associated genes across the seven reference tissues for which accurate cellular 
longevity data are available (Table 2 and Supplementary table 1). It is to be noted that, in identifying these 81 
PMCL-associated genes, multiple testing corrections where not carried out due to the low statistical power 
derived from using only seven reference tissues. This means that a true association between these genes and 
post-mitotic maintenance cannot be necessarily inferred merely on the basis of our two selection criteria. The 
only way to test whether this set of genes is genuinely associated to post-mitotic maintenance is by examining 
their collective expression using independent data (not included in their original selection).  If our candidate 
set of genes was the random outcome of a multiple testing artefact we would expect these genes not to display 
a consistent pattern of statistical association with cellular longevity when examining expression data derived 
from independent sources and/or separate tissues.  
To this end, we conducted three separate paired comparisons using independent expression data and tissues. It 
is important to highlight that although each of the identified PMCL-associated genes display a strong 
statistical correlation with cell turnover, we do not expect each and all of them to be more highly expressed in 
any given tissue when compared with a shorter living one. Rather, we should expect PMCL-genes as a whole 
to be, on average, more highly expressed in longer living tissues than short-living tissues (even though 
individual genes in this signature may show a reversed trend). In an initial test of consistency, we used data 
from occipital lobe and skin which are also included in dataset 1 but were not originally used to identify our 
set of PMCL-associated genes. While we lacked radio carbon-based estimates of skin cell turn-over, other 
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methods place this value between the 39-61 days range in humans (Bergstresser and Taylor, 1977; Iizuka, 
1994; Weinstein et al., 1984). On the other hand, since little or no neuronal turnover has been observed in 
human brain cortex and up to 50% of cortical cells are neurons (Azevedo et al., 2009; Bhardwaj et al., 2006; 
Spalding et al., 2005), we should expect the expression of PMCL-associated genes to reflect that of a long and 
short living tissue for occipital cortex and skin respectively.  We found that 61 out of 81 of our PMCL-
associated candidates displayed higher expression in the occipital cortex than in the skin. As all expression 
data was originally normalized to mean expression levels, this expression bias was significantly stronger than 
expected by chance (X2 = 20.75, p = 5.22x10-6), demonstrating that, collectively, PMCL-associated genes 
display a higher level of expression in the long living occipital cortex than in the skin. 
For the second and third test, we used additional expression data from a separate microarray dataset containing 
at least 8 biological replicates of gene expression measures derived from normal human brain, skeletal muscle 
and skin (Dataset 2, Table 1), and compared the differences  in average expression level of PMCL-associated 
genes across these tissues specifically comparing skin and muscle expression on the one hand and muscle and 
brain expression on the other. As shown in Figure 1C, the expression of PMCL-associated genes was 
sistematically higher in the brain relative to skeletal muscle (paired t test = 2.23, p = 0.014), while expression 
in the latter was also systematically higher relative to skin (paired t test = 18.02, p = 2.2x10-16).  With a 
combined probatility of PMCL-associated genes being the random outcome of a multiple testing artifact of p = 
1.6x10-23. these results demonstrate  a robust and consistent association between the level of expression of this 
set of genes and post-mitotic cellular longevity in different tissues. 
   
3.2. PMCL-associated genes display consistently higher coexpression in longer-living tissues  
Gene co-expression analysis has been widely used to gain insights into the functional organization of 
transcriptomes across tissues, conditions and species (Obayashi and Kinoshita, 2011; Oldham et al., 2006; 
Oldham et al., 2008; Saris et al., 2009; Torkamani et al., 2010; Usadel et al., 2009; Zhang et al., 2012). As 
noted, genes involved in related biological pathways display correlated expression patterns reflecting their 
functional association (Eisen et al., 1998; Homouz and Kudlicki, 2013). Candidate PMCL-associated genes 
were required to show a high degree of co-expression across a wide range of tissues, but if they are 
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functionally related with each other specifically in the context of PMCL, we would expect them to display a 
higher level of co-expression in tissues where long-term maintenance or cellular longevity demands are high 
when compared to shorter living tissues. We tested this hypothesis by re-examining the expression data from 
the original 7 tissues used to identify these genes. Because these genes were selected for being highly 
correlated with cellular longevity in these particular set of tissues (as shown in Figure 1B), we expect them to 
be overall highly co-expressed with each other relative to the background gene population in these very same 
samples. However, when we split these seven tissues into two subgroups with the top four long-living tissues 
in one group (cerebellum, cardiomyocytes, pancreatic islets and small intestine parenchyma) and the bottom 
short-living tissues in the other (small intestine parenchyma, skeletal muscle, adipocytes and whole blood), 
and obtained the average correlation coefficient across all possible pairs of PMCL-associated genes (see 
methods) within each group, we found that only the top long living tissues displayed a significantly high level 
of co-expression, with short living tissues displaying near to background levels of gene co-expression (Figure 
2A).  
In order to confirm the observed pattern of higher co-expression in longer living tissues, we took advantage of 
existing biological replicas for each of the different tissues contained in the microarray dataset 2 and obtained 
the average correlation coefficient of PMCL-associated genes for brain, muscle and skin tissue separately. The 
expected mean correlation was also estimated using 100 000 random samples from the overall gene 
population. As shown in Figure 2B, the average correlation coefficient among PMCL-associated genes in the 
brain is again significantly higher than expected by chance in the background gene population. Interestingly, 
this level of co-expression gradually decreased in muscle and skin. This result further suggests the level of co-
expression among PMLC-associated genes could vary in line with cell longevity needs in different tissues and 
that these genes display their highest co-expression in the long-living nervous tissue.  
Along these lines, using human brain RNA-seq data from 12 separate cortical regions and 20 different 
developmental time points spanning post-conception week 12 through to 40 years of age extracted from the 
BrainSpan database (Dataset 3, Table 1), we found that PMCL-associated genes display stronger average co-
expression in the neocortex compared to the average co-expression of 100 000 equally sized random samples 
of genes drawn from the overall gene population (p < 1x10-5; Figure 2C). 
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Taken together these results demonstrate, using expression data from three independent sources, that PMCL-
associated genes are highly co-expressed in long living tissues and less co-expressed in shorter living tissues, a 
result consistent with the notion that these genes display a higher functional association in longer living 
tissues. 
 
3.3.  PMCL-associated genes are enriched in specific biological processes and transcription factors 
targets.   
If our candidate PMCL-associated genes are functionally related we would expect them to display not only a 
prominent level of co-expression but also to share common pathways and biological processes. In order to 
identify possible pathways and biological processes significantly overrepresented among these genes, we 
conducted a gene ontology (GO) term enrichment analysis. We specifically looked at biological process 
categories contained in the GO slim subset of terms (http://geneontology.org) and Benjamini-Hochberg 
multiple testing corrections were carried out against the number of categories tested. Eight biological 
processes were found overrepresented: cytoskeleton-dependent intracellular transport, tRNA metabolic 
process, cell cycle, cell morphogenesis, protein folding, cell division, cellular amino acid metabolic process 
and ribosome biogenesis (Table 3). 
As noted above, PMCL-associated genes display a higher level of transcriptional coordination with each other 
in longer living tissues, possibly indicating that these genes are, to a significant extent, under concerted 
transcriptional regulation. Transcription factors (TF) are key components of regulatory cascades involved in 
coordinating gene expression. Enrichment of specific TF targets among PMCL-associated genes can provide 
additional insights into the general regulation of post-mitotic maintenance and functional stability.  To this 
end, we used Transcription factor target annotations obtained from the Molecular Signatures Database 
(MSigDB v4.0) and found that our set of PMCL-associated genes is significantly enriched in genes with 
binding sites for HSF, ELK1, EFC (RFX1),  USF and USF2 (Table 3), in addition to genes containing the SP1 
binding motif V.SP1_01 (adj. p = 0.043). Taken together, these results demonstrate that distinct biological 
processes as well as specific transcription factors targets are statistically overrepresented among genes whose 
expression patterns are closely associated with changes in post-mitotic cell longevity.  
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3.4.  PMCL-associated genes are down-regulated in Alzheimer’s and Parkinson’s disease as well as 
Hutchinson-Gilford Progeria syndrome 
So far we have looked at the pattern of expression of PMCL-associated genes comparing different tissues with 
differential maintenance requirements. However, if the level of activation of PMCL-associated genes is 
functionally linked to changes in long term post-mitotic maintenance, we should also expect these genes to be 
abnormally expressed in degenerative conditions involving reduced cell survival or compromised functional 
stability. As stated above, nerve cells require sustained maintenance mechanisms that allow them to 
individually survive and preserve their functional complexity for the entire lifetime of the organism, and 
failure of these supporting mechanisms are likely to lead to a wide range of neurodegenerative conditions. 
In order to determine if defective patterns of expression of PMCL-associated genes are significantly associated 
with degenerative conditions, we looked at two well-known neurodegenerative pathologies, Alzheimer’s and 
Parkinson’s disease in addition to Hutchinson-Gilford progeria syndrome, a condition involving a systemic 
failure of cell maintenance mechanisms linked to normal ageing, such as compromised DNA repair, genome 
instability and premature senescence (Burtner and Kennedy, 2010; Coppede and Migliore, 2010; Kudlow et 
al., 2007; Musich and Zou, 2011). For this, we used available microarray expression data derived from 87 
samples from Alzheimer’s disease patients comprising five different cortical regions and hippocampus, 24 
biological samples of substantia nigra from Parkinson’s disease patients, as well as 2 biological samples 
derived from fibroblasts of Hutchinson-Gilford syndrome patients with corresponding controls for each 
condition (n = 74, 11 and 2 arrays respectively, Dataset 4, Table 1). A paired t-test comparison between each 
condition and their corresponding controls revealed a statistically significant decrease in the average 
expression of PMCL-associated genes in each of these conditions relative to their healthy counterparts (Figure 
3A).  
Using a complementary approach, we applied linear models of microarray analysis (LIMMA) to identify 
genes displaying significant down regulation in each condition, relative to the corresponding control 
microarrays. The resulting list of down-regulated genes in each condition was then used to conduct an 
enrichment analysis aimed at detecting overrepresentation of disease-related down-regulated genes among 
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PMCL-associated genes. As shown in Figure 3B, the observed proportion of PMCL-associated  genes that are 
also down-regulated in the cerebral cortex of Alzheimer’s disease patients  is significantly higher than 
expected by chance (p < 1x10 -6). Because Dataset 4, contains at least nine biological replicas for each of six 
separate cortical regions (entorhinal cortex, superior frontal gyrus, posterior cingulate cortex, visual cortex and 
medial temporal gyrus) as well as hippocampus plus corresponding healthy controls, we were able to assess 
down regulation of PMCL associated genes in each region separately, and found  that the proportion of 
PMCL-associated genes down-regulated in AD was significantly higher than random expectations in all  
regions except the primary visual cortex and superior frontal gyrus. Likewise, the proportion of PMCL-
associated genes that were also down-regulated in the substantia nigra of Parkinson’s disease patients  as well 
as in Hutchinson-Gilford syndrome (progeria)-derived fibroblasts was significantly higher than expected by 
chance  (p = 3x10-6 and  1.35x10-4 respectively, Figure 3B).   
Taken together, these results demonstrate that, collectively, PMCL-associated genes are down-regulated in the 
cerebral cortex and substantia nigra of Alzheimer’s disease and Parkinson’s disease patients respectively as 
well as in Hutchinson-Gilford syndrome-derived fibroblasts.  
 
3.5.  Down regulation of PMCL-associated genes in degenerative conditions is specifically linked to their 
association with cellular longevity  
The above results offer the opportunity to assess whether the observed down regulation of PMCL-associated 
genes in degenerative conditions is specifically linked to their underlying association with cellular longevity. 
Because the seven reference tissues used to identify these genes differ in more than one aspect, it is 
conceivable that alternative selections based on other quantitative differences among these cell types could 
have led to the exact same results, thereby demonstrating a lack of association between post-mitotic cellular 
longevity and the down regulation of these genes in degenerative conditions. Because different cellular traits 
would be typically associated to different rankings or orderings of the reference tissues, one way to assess the 
effect of potentially different phenotypes in the selection of genes and their down regulation in these 
conditions, is by looking at gene sets “selected” based on all the possible different permutations of these 
tissues. 
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To these end, using the same strategy we previously used to identify PMCL-associated genes, we selected 
alternative sets of genes derived from each 5 040 possible permutations of the original cellular longevity 
values. For each permutation, we measured the degree of similarity with the original ordering by means of the 
correlation coefficient between the original longevity values and the permuted one. For all permutations above 
any given similarity value, we  measured the proportion of those permutations that also led gene sets 
significantly down-regulated in each of the degenerative conditions examined. As shown in Figure 4, the 
proportion of “selected” gene sets that were also down-regulated in these conditions remains close to zero for 
low minimal similarity values. This proportion, however, increases abruptly as the similarity between the 
alternative ranking and a PMCL-based ranking approaches 1. These results demonstrate that the more similar 
any of these rankings is to the original PMCL-based ranking, the higher the proportion of resulting gene sets 
that are also down-regulated in these degenerative conditions. In other words, these results demonstrate that 
the observed down regulation of PMCL-associated genes in degenerative conditions is specifically linked to 
their underlying association with cellular longevity. 
 
3.5.  PMCL-associated genes display reduced patterns of coordinated expression in Alzheimer’s and 
Parkinson’s disease 
  As mentioned before, genes involved in related biological pathways tend to display coordinated expression 
patterns reflecting their functional association (Eisen et al., 1998; Homouz and Kudlicki, 2013). Having 
observed a significant reduction in the collective expression of PMCL-associated genes in degenerative 
conditions, we asked whether these genes also display a concomitant reduction in coordinated expression in 
these pathological conditions. 
To this end we calculated the average correlation of across all possible pairs of PMCL-associated genes in 
both AD and PD and compared these values with those obtained for the corresponding controls. Due to the 
low number of replicas for HGPS, this condition was not included in this analysis. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
17 
 
As shown in figure 5, a highly significant reduction in the average correlation of PMCL-associated genes was 
observed for both AD and PD, revealing a significant functional dissociation of these genes in these two 
degenerative conditions.  
 
3.6. Sexual expression dimorphism of PMCL-associated genes in the brain reflect sexual differences in 
life expectancy in humans and macaques  
Because nerve cells survive as long as the organism, any consistent and systematic differences in overall life 
expectancy between individuals could potentially entail differential survival demands for nerve tissues.   
Human females outlive their male counterparts with women living on average 6% more than men (Clutton-
Brock and Isvaran, 2007; Kinsella, 1998; Vina and Borras, 2010; Vina et al., 2005).  While the cellular and 
genetic mechanisms underlying sexual lifespan dimorphism are still poorly understood, proposed mechanism  
include differences in telomere dynamics (Barrett and Richardson, 2011; Jemielity et al., 2007), differential 
response to oxidative stress (Ballard et al., 2007) and asymmetric inheritance of sex chromosomes and 
mitochondria (Camus et al., 2012; Gemmell et al., 2004). In order to test whether brain expression of PMCL 
associated genes reflect sexual dimorphism in life expectancy, we compared their expression using existing 
RNA-seq data from both male and female individuals (Dataset 5, Table 1).    A paired t-test comparison of the 
expression levels of all PMCL-associated genes between males and females in humans revealed a statistically 
significant increase in the average expression difference of PMCL-associated genes in females relative to 
males (Figure 6A). 
Using a complementary approach, we used separate RNA-seq expression data derived from 15 brain regions 
from a 40 year old man and woman derived from a different source (Dataset 3, Table 1) and extracted a list of 
genes significantly up regulated  in the female transcriptome (see methods). We then used this list to conduct 
an enrichment analysis aimed at detecting over-representation of female up-regulated genes among our set of 
PMCL-associated genes. The expected proportion was numerically calculated based on 1 000 000 equally-
sized random gene samples drawn from the overall gene population. As shown in Figure 6B, the observed 
proportion of PMCL-associated genes that are also up regulated  in  females relative to males is significantly 
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higher than expected by chance  (p = 0.003). These results show, using two independent sources of expression 
data, that in the human nervous system, PMCL-associated genes are collectively up-regulated in females 
relative to males. Other species primate species display a stronger sexual dimorphism in life expectancy than 
humans;  in particular macaques display a more pronounced sexual lifespan dimorphism with females living 
on average 72% more than males in the wild (Clutton-Brock and Isvaran, 2007), a difference potentially 
entailing substantially higher neuronal survival and functional stability demands in female macaques 
compared to males.  Interestingly, a paired t-test comparison of the expression levels of all PMCL-associated 
genes between females and males revealed a much more pronounced expression of PMCL-associated genes in 
female macaques relative to males (Figure 6A).  These results demonstrate that in the female nervous system, 
where cell survival-related requirements are likely to be higher than in males, PMCL-associated genes are 
collectively up-regulated relative to their male counterpart.  
 
 
4.  Discussion 
Terminally differentiated post mitotic cells have different turnover and survival requirements. Whether these 
differences arise from equally different cell maintenance mechanism engaged by different cell types, or the 
differential activation of an otherwise common molecular repertoire is not known. Nowhere are these 
supporting mechanisms as critical as in the nervous system where the vast majority of nerve cells cannot be 
replaced and need to survive as long as the organism, reaching in humans even 100 years or more.   
The specific regulatory events directing long term post-mitotic survival are known to differ across different 
tissues. However, the basic molecular events ensuring appropriate levels of DNA repair, protein turnover and 
stability as well as organelle integrity could, at least in principle, potentially recruit a common repertoire of 
molecular mechanism with the only difference being the level of activation of these same mechanisms in 
response to the survival requirements of different cell types and tissues.   
Because of the inevitable noise in the existing expression data and the limited number of tissues for which 
accurate  data on cellular longevity is available, our ability to identify a hypothetical cell maintenance 
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machinery specifically linked to variations in long term post-mitotic survival is necessarily limited. In spite of 
this limitation, by comparing genome-wide expression data in seven tissues ranging in cell longevity from 120 
days to over 70 years in combination with Jackknife correlations to rule out spurious effects of strong outliers, 
we detect at least 81 highly cohesive genes whose level of expression is robustly correlated with cellular 
longevity. A conceptually similar strategy has been previously used to scan for genes associated with 
increased cancer incidence in several tissues (Silva et al., 2011). However, using large scale expression data to 
scan for genes potentially involved in post-mitotic cell longevity has never been attempted before.  
Given the low statistical power associated to the use of only seven tissues, our selection of PMCL-associated 
genes was based on their associated high Jackknife correlation value rather than significance. In spite of this, 
we demonstrate that the resulting set of PMCL-associated genes and their specific nature is not the result of a 
potential multiple testing artefact. Indeed, by performing three independent tests, using additional data from 
tissues not included originally in the identification of these genes as well as two additional independent 
expression databases, we found that PMCL-associated genes as a whole systematically display higher 
expression in progressively longer-living tissues. This result is, by no mean consistent with the expected 
random outcome of a multiple testing artefact.   
Furthermore, if PMCL-associated genes are functionally linked to each other through their common 
involvement in the post-mitotic cell maintenance machinery, we would expect them to be activated in concert 
and display a high level of co-expression particularly in long living tissues. In agreement with this, using 
expression data from five independent sources we found that PMCL-associated genes display an average 
correlation significantly higher than the background gene population, especially in longer living tissues such 
as nervous system.  Moreover, we observed that these genes are progressively less co-expressed in shorter 
living tissues possibly reflecting a reduction in the concerted expression of these genes in tissues with higher 
turnover and lower demands of post-mitotic maintenance and survival. 
We further explored whether PMCL-associated genes are also differentially expressed when comparing 
different conditions potentially entailing either reduced or enhanced functional stability within the same tissue. 
As nerve cells need to individually survive and preserve their functional complexity for the entire lifetime of 
the organism, the compromised functional stability observed in neurodegenerative conditions such as 
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Alzheimer’s and Parkinson’s disease is likely to be mirrored by a corresponding breakdown and/or 
dysregulation of  basic cell supporting mechanisms.  Along these lines, we found that PMCL-associated genes 
are significantly down-regulated in the cerebral cortex and substantia nigra of Alzheimer’s disease and 
Parkinson’s disease patients respectively as well as in Hutchinson-Gilford syndrome-derived fibroblasts.  
Interestingly, PMCL associated genes showed no significant enrichment of down-regulated genes in the visual 
cortex of Alzheimer’s disease patients (Figure 3B). This result is particularly significant given that visual 
cortex is known to show the least amount of Alzheimer’s disease  related changes and is relatively spared from 
Alzheimer’s disease pathologies (Liang et al., 2008; Liang et al., 2007). The fact that additional analysis of the 
level of co-expression of PMCL-associated genes also revealed a statistically significant reduction in average 
co-expression in these degenerative conditions relative to the average correlation of these genes in normal 
controls  further supports the notion of an abnormal regulation of these genes in neurodegenerative 
pathologies. 
We further demonstrate that the observed down regulation of our set of genes in each of these conditions is 
specifically related to their underlying association with cellular longevity. We did this by following the exact 
same procedure we followed to identify our PMCL-associated genes and obtained all possible alternative gene 
sets resulting from all possible permutations of cell longevity values in the original seven tissues. We showed 
that only those permutations that match the original PMCL-based ranking of the reference tissues lead to gene 
sets that are also down-regulated in these conditions. 
These results demonstrate that the down regulation of PMCL-associated genes in three separate degenerative 
conditions is specifically linked to the PMCL-associated ranking of the reference tissues originally used to 
identify these genes. In other words the collective down regulation of these genes in degenerative conditions, 
is the result their specific association with post-mitotic cell longevity. While the present study focusses on 
transcriptional signatures instead of actual protein levels, we took advantage of recently available data derived 
from proteome profiling of both Alzheimer’s and Parkinson’s disease (Bereczki et al., 2018), and asked 
whether PMCL-associated protein products where statistically over represented among proteins down-
regulated in these conditions.  While only 74 of the 81 PMCL-associated proteins were present in these 
datasets, we found that 45% and 57% of them where absolutely down-regulated in Alzheimer’s and 
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Parkinson’s disease respectively. An hypergeometric test confirmed these proportions to be significantly larger 
than expected by chance  relative to the proportion of overall down-regulated proteins in these two conditions 
(p<0.05 in both cases). This result provides further support to the notion of an abnormal down regulation of 
PMCL-associated genes at both transcriptional and protein levels in degenerative conditions. 
Because nerve cells survive as long as the organism, any consistent and systematic differences in overall life 
expectancy between individuals are likely to be accompanied by differential survival demands in post-mitotic 
nerve tissue. In this respect, females in some mammalian species, and in particular humans, live longer than 
their male counterparts (Clutton-Brock and Isvaran, 2007; Vina and Borras, 2010; Vina et al., 2005). 
Regardless of the underlying genetic and cellular mechanisms, these sex-related differences in overall life 
expectancy are likely to translate into corresponding differences in long-term neuronal maintenance. 
Using data derived from humans and macaques, two primate species for which brain expression data in males 
and females is available in addition to reported estimates of lifespan sexual dimorphism  (Clutton-Brock and 
Isvaran, 2007; Kinsella, 1998; Vina and Borras, 2010; Vina et al., 2005), we found that the collective level of 
expression of PMCL-associated genes is significantly higher in females compared to their male counterparts in 
both species. It is worth noting that dimorphic expression of PMCL-associated genes was much more 
pronounced in macaques where differences in lifespan between females and males in the wild are also much 
greater than in humans. It should be mentioned, however, that the pronounced dimorphic lifespan in macaques 
has been observed predominantly in wild populations and some studies in captivity have actually reported an 
inverse relationship (Mattison et al., 2012). This suggests that captivity conditions could have a detrimental 
effect in survival, specifically affecting females (or a beneficial effect, specifically affecting males). If this is 
the case, our results suggest that sexually dimorphic expression of PMCL genes in macaques reflect the 
corresponding survival demands associated to the ecological conditions under which the species-specific 
regulation of these genes evolved. In all, our results demonstrate that in the female nervous system, PMCL-
associated genes are significantly up-regulated relative to their male counterpart possibly reflecting 
corresponding sex-related differences in long term neuronal maintenance requirements. It is worth mentioning 
at this point that among those PMCL-associated genes also down-regulated in Alzheimer’s disease, all but one 
of where also found significantly up-regulated in female versus male brain samples and  70% of them were 
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also down-regulated in Parkinson’s disease brains. Given that both degenerative conditions display a strong 
sex bias in prevalence, this observation suggests that sex-specific longevity-related demands of PMCL-
associated functions could indeed be linked to the corresponding sex bias in prevalence observed in both 
Alzheimer’s and Parkinson’s disease. Future analyses of expression data derived from larger samples of male 
and female individuals in both conditions will allow us to ascertain the role of sex-specific patterns of 
expression of PMCL-associated genes and observed sex bias in the incidence of these conditions.     
Both the down-regulation of PMCL-associated genes in Alzheimer’s disease and Parkinson’s disease as well 
as Progeria, together with their up-regulation in the female brain of both humans and macaques, suggest that 
these genes could constitute a potential signature of either enhanced or compromised functional stability both 
in neurons as well as other long-living cell types.  
Using gene ontology annotations and enrichment analysis we found that biological processes such as 
cytoskeletal-dependent transport, cell morphogenesis and protein folding are statistically overrepresented 
among our PMCL-associated even after correcting for multiple testing against all 69 functional categories 
tested. Crucially these genes are also enriched in targets of specific transcription factor further supporting the 
notion of these genes being part of a common pathway involved in long term cell survival and functional 
stability. Similar results were obtained when using a standard GO enrichment analysis tool such as 
WebGestalt.   
Our screening captured genes involved in resistance against protein misfolding including prefoldins (PFDN2), 
ubiquitin esterases (UCHL1), chaperonins (CCT7), chaperons (HSP90AB1) and associated adaptor proteins 
(STIP1) as well as proteosomal subunits (PSMC4).  The fact that these genes are increasingly up-regulated in 
long living tissues points towards the sustained activation of the unfolded protein response (UPR) and/or the 
proteasome pathway as a central component of the long-term survival machinery of long living tissues such as 
the nervous system.  Along these lines, both UPR and the ubiquitin/proteasome system (UPS), and indeed 
protein turnover/degradation pathways in general, have been proposed be key players in the aging process in 
different species (Durieux et al., 2011; Kimata et al., 2006; Kruegel et al., 2011; Min et al., 2008; Morley and 
Morimoto, 2004; Perez et al., 2009). (Lee et al., 1999; Lee et al., 2000). Oxidative stress can cause protein 
misfolding and improperly folded proteins that are either retained within the lumen of the endoplasmic 
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reticulum (ER) in complex with molecular chaperones or degraded through the 26S proteasome or through 
autophagy. Accumulation of misfolded proteins is also known to cause ER stress, which in turn can exacerbate 
oxidative stress (Gregersen and Bross, 2010; Malhotra and Kaufman, 2007).  HSP90 is known to modulate the 
unfolded protein response (UPR) (Marcu et al., 2002) and targeting HSP90 can destabilise UPR induced cell 
death (Barrott and Haystead, 2013; Davenport et al., 2008; Jackson, 2013). Interestingly, mutants of HSP90 
are known to affect lifespan in C. elegans, D. melanogaster and S. cerevisiae.  
Organismal ageing is a process that involves a progressive decrease in the capacity to adequately maintain 
tissue homeostasis (Burton, 2009; de Jesus and Blasco, 2012; de Magalhaes and Faragher, 2008; de Magalhaes 
et al., 2012; Dutta et al., 2012; Manayi et al., 2014; Terman et al., 2010). Being such a complex process ageing 
involves a large number of changes at various physiological levels and could, at least in principle also involve 
the gradual breakdown in post mitotic cell maintenance. With this in mind we looked into any potential 
overlaps between post-mitotic cell longevity genes and genes known to be associated with ageing.   To this 
end, we examined the GenAge database of genes related to ageing   (Tacutu et al., 2013), and after comparing 
with PMCL-associated genes a number functional links between both sets of genes were apparent. For 
example, GenAge lists a number of genes, including E2F1, p53, CDKN1A, PPP1CA, known to be regulated 
by the transcriptional intermediary factor TRIM28 which we found among our PMCL-associated genes and is 
involved in development and DNA repair. Conversely, GeneAge lists transcription factor SP1 and we found a 
significant overrepresentation of genes with a particular SP1 binding site in their promoter regions, among our 
gene set. We also identified COX8A, a cytochrome c oxidase, a finding consistent with the fact that GenAge 
also includes cytochrome c oxidase (MT-CO1) as well as COXPD6, a pro-apoptotic factor involved in its 
release from the mitochondria. While GenAge contains the gene encoding for the catalytic subunit of the 
protein phosphatase 1 (PPP1CA) and several of its regulators (BRCA1, BCL2 and PTK2; all of them members 
of the PPP1R family) we identify another regulator, PPP1R7 among our PMCL- associated genes. 
Furthermore, both gene sets contain genes involved in the ubiquitin mediated proteolysis pathway (e.g. 
UCHL1, UBE2I, UBB, and USP14). We also identified HSP90AB1 and its co-chaperones CDC37 and STIP1, 
whereas GenAge points towards chaperones HSP90AA1, HSPD1, HSPA1A, HSPA1B, HSPA8, and STUB1 
(Apweiler et al.; Stelzer et al.).  
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Prompted by the potential association  between PMCL-associated genes and aging-related processes we 
looked at differentially expressed genes in the brain of mice subjected to caloric restriction (CR), an 
experimental dietary regime known to slow down ageing-related changes in many animal models  (Barger et 
al., 2008). It is worth noting in this regard that transcriptional patterns of calorie-restricted animals suggest 
that caloric restriction retards the aging process by causing a metabolic shift toward increased protein turnover 
and decreased macromolecular damage (Lee et al., 1999), a finding consistent with the significant 
overrepresentation of protein turnover/degradation pathways observed among the PMCL-associated genes 
identified in the present study. Using available expression data we found a statistically significant 
overrepresentation of PMCL-associated genes among CR up-regulated genes (Dataset 6, table 1; p = 0.041). 
An even more pronounced effect was found when using human data (Mercken et al., 2013) derived from 
skeletal muscle of human individuals subjected to CR (Dataset 6, table 1; p = 0.0082).  Differences among 
neuronal populations in the production and/or clearance of abnormal proteins are thought to be key 
determinants of age-related neuronal vulnerability in Alzheimer's disease, Parkinson's disease (PD) and 
Huntington's disease (HD) (Lam et al., 2000; Mattson and Magnus, 2006; McNaught et al., 2001). In this 
regard, several of the adverse consequences of ageing and neurodegenerative disorders on neuronal function, 
morphology and survival, as well as behavioural alteration, can be mimicked by pharmacological inhibition of 
proteasomes (Romero-Granados et al., 2011; Sullivan et al., 2004). Interestingly, loss of function of UCH-L1 
in mice is known to cause gracile axonal dystrophy (gad) phenotype resulting in sensory–motor ataxia (Saigoh 
et al., 1999). Importantly, these mutants also showed axonal degeneration and formation of spheroid bodies in 
nerve terminals and an accumulation of amyloid β-protein (Aβ) and ubiquitin-positive deposits, suggesting 
that UCH-L1 is involved in neurodegenerative disorders. On the other hand, in amyloid pathogenesis, 
overexpression of Hsp70 and Hsp90 has been shown to decrease Aβ aggregation (Evans et al., 2006), reduce 
Aβ-mediated neuronal toxicity, and appears to enhance the chaperone-mediated clearance of amyloid 
precursor protein (APP) and its amyloidgenic Aβ derivatives (Kumar et al., 2007). Indeed, modulation of 
HSP90 has been proposed as a therapeutic tool against Alzheimer’s disease (Zhao et al., 2012). 
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5.  Conclusions 
Taken together, our results support the notion of a common molecular repertoire of cellular maintenance 
mechanisms shared by all terminally differentiated post-mitotic cells and show that these same mechanisms 
are differentially engaged in different cell types with different survival requirements. In addition, our results 
strongly suggest a close connection between PMCL-associated genes and the wider genetic machinery of long 
term post-mitotic maintenance and functional stability both in neural and non-neural tissues. Furthermore, the 
observed down regulation of these genes in models of neuronal degeneration and reduced lifespan, identify 
PMCL-associated genes as robust molecular markers of either compromised or enhanced cell survival both in 
neural and non-neural tissues. This is the first genome-wide analysis suggesting the existence of a generalised 
cell longevity pathway in human tissues. Identifying the underlying maintenance mechanisms that allow long 
living tissues, such as nerve cells, to preserve their functional and structural integrity for the entire lifetime of 
the organism will be central four our understanding of aging and neurodegeneration in addition to the unique 
cell survival capabilities of the human nervous system.    
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Figure Legends 
 
Figure 1. Transcriptional signature of cell longevity-associated genes across different tissues  A) Chart 
showing a significant bias towards a positive associations between expression levels across the whole gene 
population and PMCL.  Jackknife correlation against post-mitotic longevity values for seven reference tissues 
was computed for each of the 11 449 genes for which expression data were available in all these tissues and 
the overall mean Jackknife value across all genes was computed (Observed Jk R, blue arrow).  Histogram in 
chart shows the expected mean Jackknife values resulting from 1000 independent random permutations of 
cellular longevity estimates (numerical p<0.001, Z test p value <0.00000 (Zscore=23)).  B) Regression plot 
showing the average normalized expression of 81 PMCL-associated genes as a function of cell longevity in 7 
separate tissues for which carbon dating estimations are available. Expression data used corresponds to dataset 
1 and each individual data point represents the average normalized expression of all 81 genes. Pearson 
correlation coefficient and associated p-value are indicated. C) Fold-change in gene expression for each 
PMCL-associated gene comparing skin vs muscle expression and muscle vs brain expression respectively. 
Each arrow represents the direction in  –log2 (fold change) for each particular PMCL-associated gene and each 
indicated pair of tissues. Indicated p-values for the observed average differences in expression of PMCL-
associated genes were obtained using paired t-test per comparisons.   
 
Figure 2. PMCL-associated associated genes are more highly co-expressed in longer living tissues A) Bar 
graph showing the observed average correlation coefficient (±SEM) of all possible pairs of PMCL associated 
genes (green bar) across the top four long-living tissues (cerebellum, cardiomyocytes, pancreatic islets and 
small intestine) on the one hand, and the bottom four shortest living tissues (small intestine, skeletal muscle, 
adipocytes and whole blood) on the other (Dataset 1, Table 1). B) Bar graph representing the observed average 
correlation coefficient (±SEM) of all possible pairs of PMCL associated genes (green bar), compared to the 
expected average correlation (grey bar) using microarray data from 8 biological replicas (Dataset 2, Table 1) 
of brain, skeletal muscle and skin tissue. C) Bar graph representing the observed average correlation 
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coefficient (±SEM) of all possible pairs of PMCL associated genes (green bar), compared to the expected 
average correlation (grey bar), using expression data from 240 separate cerebral cortex samples obtained from 
the BrainSpan dataset (Dataset 3, Table 1). For each analysis, p-values and the expected mean correlations 
(grey bars ±SEM), was numerically calculated using 100 000 equally sized random samples drawn from the 
overall gene population.  *** p < 0.0001, ** p < 0.001, * p < 0.05. 
 
Figure 3. PMCL-associated genes are down-regulated in Alzheimer’s and Parkinson’s disease as well as 
Hutchinson-Gilford syndrome. A) fold-change in gene expression for each PMCL-associated gene relative 
to their control counterpart for each indicated condition. Each arrow represents the direction in  –log2 (fold 
change) for each particular PMCL-associated gene in each indicated condition. P-values for the observed 
average differences in expression of PMCL-associated genes, between control and disease samples, were 
obtained using paired t-test.  B) Microarray data from brain cortex (n = 161), substantia nigra (n = 35) and 
fibroblasts (n = 2) obtained from Alzheimer’s disease (AD),  Parkinson’s disease (PD) patients and 
Hutchinson-Gilford syndrome progeria patients (HGPS),  respectively, were used along with corresponding 
controls to identify genes significantly down-regulated in each condition.  The chart shows the distribution of 
expected proportion of down-regulated PMCL-associated genes for each condition, using 1 000 000 random 
samples of 81 genes. Blue arrow indicates the actual proportion and associated probabilities of PMCL-
associated genes down-regulated in each indicated condition. Inset: significance of enrichment of down-
regulated PMCL-associated genes for each separate brain region in AD patients with the dashed line 
representing the adjusted significance threshold (EC: entorhinal cortex; PC: posterior Cingulate cortex; MTG: 
medial temporal gyrus; HIP: hippocampus; SFG: superior frontal gyrus and VCX: visual cortex). Note that the 
proportion of PMCL-associated genes down-regulated in AD was significantly higher than expected in all 
regions except the primary visual cortex and superior frontal gyrus.    
 
Figure 4. Down regulation of PMCL-associated genes in degenerative conditions is specifically linked to 
their association with cellular longevity. Following the same strategy to identify PMCL-associated genes, 
we selected alternative sets of genes highly correlated with each of the 5 040 possible permutations of the 
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original seven cell longevity values. For each permutation, we measured the degree of similarity with the 
original ordering by means of their correlation coefficient.  A-C; Each graph shows for all permutations above 
a given similarity value (x axis), the proportion of permutations leading to gene sets as significantly down-
regulated in each of the indicated degenerative conditions as the real ordering. Note that the proportion of 
significantly down-regulated gene sets only raises when the minimal similarity between the permuted and the 
original ordering of longevity values approaches 1. AD: Alzheimer disease; PD: Parkinson’s disease; HGPS; 
Hutchinson Gilford progeria syndrome. 
 
Figure 5.  PMCL-associated genes display reduced patterns of coordinated expression in Alzheimer’s 
and Parkinson’s disease Using expression data derived from dataset4 (table 1) we calculated the average 
correlation of across all possible pairs of PMCL-associated genes in both Alzheimer’s (A) and Parkinson’s 
disease and compared these values with those obtained for the corresponding controls.  
 
Figure 6. Sexual expression dimorphism of PMCL-associated genes in the brain reflects sexual 
differences in longevity in human and macaque. A) fold-change in gene expression for each PMCL-
associated gene comparing males and females in human and macaque. Each arrow goes from –log2 (♂/♂ 
expression) to log2 (♀/♂ expression) for each particular PMCL-associated gene. p-values for the observed 
average differences in brain expression of PMCL-associated genes between the two sexes for each species 
were obtained using paired t-tests.  B) Distribution of the expected proportion of PMCL-associated genes up-
regulated in females relative to males using 1 000 000 random samples of 81 genes. A linear model was used 
to detect genes significantly up-regulated in females using RNA-seq data from 30 different brain samples of 
40 year old human subjects obtained from the BrainSpan dataset. The blue arrow indicates the actual 
proportion of PMCL-associated genes up-regulated in females relative to males.   
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Tables 
Table 1. Sources of gene expression data* 
Dataset Source (tissue and condition) Platform Reference 
1 BioGPS  (79 normal human tissues) RNA Microarray (Su et al., 2004) 
2 GSE13162 (Normal frontal cortex) 
GSE11681–GPL96 (Normal muscle) 
GSE42114 (Normal skin) 
RNA Microarray 
RNA Microarray 
RNA Microarray 
(Chen-Plotkin et al., 
2008) (Saenz et al., 
2008) (Gulati et al., 
2013) 
3 Brainspan (Normal Cortex) RNA-seq (www.brainspan.org) 
4 GSE5281(Cortex & 
hippocampus/AD) 
GSE8397-GPL96 (Substantia 
nigra/PD) 
GSE24487 (Fibroblasts) 
RNA Microarray 
RNA Microarray 
RNA Microarray 
(Liang et al., 2008) 
(Moran et al., 2006) 
(Liu et al., 2011) 
5 Brawand et al. supplementary 
material (male/female, Human 
&Macaque brain) 
RNA-seq (Brawand et al., 2011) 
6 GSE11291 (Mouse Muscle/CR) 
GSE38012 (Human Muscle/CR) 
RNA Microarray 
RNA Microarray 
(Barger et al., 2008) 
(Mercken et al., 2013) 
*Refer to methods (section 2.2) for a more detailed description  
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Table 2. PMCL-associated genes 
Symbol Gene Name Jackknife 
R 
Symbol Gene Name Jackknife 
R 
CCT7 T-complex protein 1 subunit eta 0.968 MEA1 male-enhanced antigen 1 0.802 
UCHL1 ubiquitin carboxyl-terminal hydrolase 
isozyme L1 
0.934 PAPSS1 3'-phosphoadenosine 5'-
phosphosulfate synthase 1 
0.944 
PSMC4 26S protease regulatory subunit 6B 0.933 TPI1 triosephosphate isomerase 1 0.811 
HSP90AB1 heat shock protein HSP 90-beta 0.933 COL13A1 collagen, type XIII, alpha 1 0.855 
COPZ1 coatomer subunit zeta-1 0.901 NES nestin 0.825 
PFDN2 prefoldin subunit 2 0.875 MYH10 myosin-10 0.821 
COPS6 COP9 signalosome subunit 6 0.834 ITM2C integral membrane protein 2C 0.883 
USP14 ubiquitin specific peptidase 14 0.83 ATXN2 ataxin 2 0.881 
CDC37 cell division cycle 37 0.813 ATXN10 ataxin 10 0.865 
TUBB4B tubulin beta-4B chain 0.818 TMEM132A Heat Shock 70kDa Protein 5 
Binding Protein 1 
0.836 
MZT2B mitotic spindle organizing protein 2B 0.972 XRCC6 X-ray repair cross-complementing 
protein 6 
0.832 
TUBGCP2 gamma-tubulin complex component 2 0.879 TEK angiopoietin-1 receptor 0.821 
FAM96B family with sequence similarity 96, 
member B 
0.861 TRIM28 tripartite motif containing 28 0.817 
CKAP5 cytoskeleton associated protein 5 0.861 SLC7A5 large neutral amino acids 
transporter small subunit 1 
0.801 
MAPK6 mitogen-activated protein kinase 6 0.857 ARL3 ADP-ribosylation factor-like 3 0.916 
DCTN3 dynactin 3 (p22) 0.84 UNC5B netrin receptor UNC5B 0.91 
NUDC nuclear migration protein nudC 0.828 GPI glucose-6-phosphate isomerase 0.867 
ACTR1A alpha-centractin 0.815 SMARCA4 transcription activator BRG1 0.931 
PPP1R7 protein phosphatase 1 regulatory subunit 7 0.804 SSRP1 structure specific recognition 
protein 1 
0.84 
YWHAE 14-3-3 protein epsilon 0.803 STIP1 stress-induced-phosphoprotein 1 0.866 
EID1 EP300 interacting inhibitor of 
differentiation 1 
0.818 SLC3A2 4F2 cell-surface antigen heavy 
chain 
0.889 
PPM1G protein phosphatase 1G 0.808 EPM2AIP1 EPM2A-interacting protein 1 0.833 
PAPD7 PAP associated domain containing 7 0.836 PTS 6-pyruvoyltetrahydropterin 
synthase 
0.95 
CBX5 chromobox homolog 5 0.964 PFKP 6-phosphofructokinase type C 0.863 
ATP13A2 ATPase type 13A2 0.895 COX8A cytochrome c oxidase subunit 8A 0.834 
PNMA2 paraneoplastic antigen Ma2 0.891 ATP6V1H V-type proton ATPase subunit H 0.801 
RRAGA Ras-related GTP binding A 0.814 CHCHD2 coiled-coil-helix-coiled-coil-helix 
domain containing 2 
0.809 
UBE2Z ubiquitin-conjugating enzyme E2Z 0.832 NHP2L1 NHP2-like protein 1 0.959 
YARS tyrosyl-tRNA synthetase 0.853 EXOSC10 exosome component 10 0.819 
MAGED1 melanoma antigen family D, 1 0.946 NHP2 NHP2 ribonucleoprotein 0.901 
NPDC1 neural proliferation, differentiation and 
control, 1 
0.901 GTF3C4 general transcription factor 3C 
polypeptide 4 
0.816 
AKT3 RAC-gamma serine/threonine-protein 
kinase 
0.869 VDAC2 voltage-dependent anion channel 2 0.837 
NR2F1 COUP transcription factor 1 0.868 EEF1E1 eukaryotic translation elongation 
factor 1 epsilon 1 
0.875 
HDGFRP3 Hepatoma-derived growth factor-related 
protein 3 
0.866 HARS histidyl-tRNA synthetase 0.824 
RBFOX2 RNA binding protein fox-1 homolog 2 0.837 SARS seryl-tRNA synthetase 0.812 
PDXK pyridoxal kinase 0.825 NUCKS1 nuclear casein kinase and cyclin-
dependent kinase substrate 1 
0.891 
FLNB filamin-B 0.814 BRD9 bromodomain containing 9 0.842 
FEV protein FEV 0.813 GPKOW G patch domain and KOW motifs 0.825 
IFT46 intraflagellar transport protein 46 homolog 0.81 SETD5 SET domain containing 5 0.816 
PFN2 profilin 2 0.807 FAM171A1 protein FAM171A1 0.809 
LARP1 la-related protein 1 0.803    
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Table 3. GO slim terms and transcription factor target significantly enriched among 
PMCL-associated genes (Adjusted p-value < 0.05) 
 
Gene ontology 
accession Gene ontology term O/E Adj. p 
GO:0030705 cytoskeleton-dependent intracellular transport 3 / 0.36 0.0003 
GO:0006399 tRNA metabolic process 4 / 0.69 0.0013 
GO:0007049 cell cycle 15 / 6.17 0.0024 
GO:0000902 cell morphogenesis 11 / 4.41 0.0101 
GO:0006457 protein folding 4 / 1.12 0.0491 
GO:0051301 cell division 6 / 2.27 0.0491 
GO:0006520 cellular amino acid metabolic process 6 / 2.25 0.0491 
GO:0042254 ribosome biogenesis 3 / 0.80 0.0491 
    
Transcriptional factor binding site O/E Adj. p 
HSF 6 / 1.55 0.0416 
USF2 5 / 1.27 0.0416 
USF 10 / 3.93 0.0416 
ELK1 15 / 6.87 0.0416 
EFC (RFX1) 5 / 1.34 0.0494 
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Highlights: 
 
• Comparing transcriptomes across tissues identify genes correlated with cell longevity. 
• Cell longevity-genes are more highly coexpressed in brain and longer living tissues 
• Cellular longevity-genes are downregulated in neurodegenerative conditions  
• Sexually dimorphic expression of these genes reflects dimorphism in lifespan. 
 
 
